Fig. 11From: Pharmacological mechanism underlying anti-inflammatory properties of two structurally divergent coumarins through the inhibition of pro-inflammatory enzymes and cytokinesMolecular docking study of calipteryxin (a) and (3’S,4’S)-3’,4’-disenecioyloxy-3’,4’-dihydroseselin (b)Back to article page